SCIENTIFIC GAMES CORP (SGMS)

US80874P1093 - Common Stock

58.07  +1.32 (+2.33%)

After market: 58.07 0 (0%)

Fundamental Rating

2

Taking everything into account, SGMS scores 2 out of 10 in our fundamental rating. SGMS was compared to 135 industry peers in the Hotels, Restaurants & Leisure industry. SGMS has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, SGMS is valued expensive at the moment.



1

1. Profitability

1.1 Basic Checks

SGMS had positive earnings in the past year.
In the past 5 years SGMS reported 4 times negative net income.
In the past 5 years SGMS always reported a positive cash flow from operatings.

1.2 Ratios

Industry RankSector Rank
ROA 4.52%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM 13.15%
PM (TTM) 12.35%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

2

2. Health

2.1 Basic Checks

SGMS has more shares outstanding than it did 1 year ago.
The debt/assets ratio for SGMS has been reduced compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of 0.37, we must say that SGMS is in the distress zone and has some risk of bankruptcy.
SGMS has a Debt/Equity ratio of -3.83. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity -3.83
Debt/FCF N/A
Altman-Z 0.37
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

SGMS has a Current Ratio of 1.78. This is a normal value and indicates that SGMS is financially healthy and should not expect problems in meeting its short term obligations.
A Quick Ratio of 1.68 indicates that SGMS should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.78
Quick Ratio 1.68

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 166.95% over the past year.
The Revenue has been growing slightly by 5.80% in the past year.
The Revenue has been decreasing by -5.67% on average over the past years.
EPS 1Y (TTM)166.95%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q200%
Revenue 1Y (TTM)5.8%
Revenue growth 3Y-13.82%
Revenue growth 5Y-5.67%
Revenue growth Q2Q-23.75%

3.2 Future

Based on estimates for the next years, SGMS will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.52% on average per year.
SGMS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.78% yearly.
EPS Next Y-61%
EPS Next 2Y-8.45%
EPS Next 3Y-7.2%
EPS Next 5Y13.52%
Revenue Next Year-10.08%
Revenue Next 2Y-0.9%
Revenue Next 3Y-0.83%
Revenue Next 5Y0.78%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 18.49, SGMS is valued on the expensive side.
Compared to an average S&P500 Price/Earnings ratio of 28.83, SGMS is valued a bit cheaper.
Based on the Price/Forward Earnings ratio of 47.42, the valuation of SGMS can be described as expensive.
SGMS is valuated expensively when we compare the Price/Forward Earnings ratio to 20.47, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 18.49
Fwd PE 47.42

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 17.68

4.3 Compensation for Growth

A cheap valuation may be justified as SGMS's earnings are expected to decrease with -7.20% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-8.45%
EPS Next 3Y-7.2%

0

5. Dividend

5.1 Amount

No dividends for SGMS!.
Industry RankSector Rank
Dividend Yield N/A

SCIENTIFIC GAMES CORP

NASDAQ:SGMS (4/28/2022, 7:26:43 PM)

After market: 58.07 0 (0%)

58.07

+1.32 (+2.33%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap5.63B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 18.49
Fwd PE 47.42
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.52%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM 13.15%
PM (TTM) 12.35%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity -3.83
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.78
Quick Ratio 1.68
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)166.95%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-61%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)5.8%
Revenue growth 3Y-13.82%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y